drug
brigatinib
Marketedupdated 4mo agoby Takeda Pharmaceuticals USA Inc
Approvedcommunity read0 votes
indications
investigational
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying brigatinib
- —Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
- phase2Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping
- —A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)
- phase2Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- phase2Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
- phase3A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
- phase2A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib
- —A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 22, 2027
267 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Nov 10, 2035compositionUS 10385078
- Nov 10, 2035compositionUS 10385078
- Nov 10, 2035compositionUS 10385078
- Apr 10, 2034method-of-use (U-2837)US 9611283
- Apr 10, 2034method-of-use (U-2837)US 9611283
- Apr 10, 2034method-of-use (U-2837)US 9611283
- Apr 28, 2031compositionUS 90124624.7y
- Apr 28, 2031compositionUS 90124624.7y
- Apr 28, 2031compositionUS 90124624.7y
- May 21, 2029method-of-use (U-2837)US 92730772.7y
- May 21, 2029method-of-use (U-2837)US 92730772.7y
- May 21, 2029method-of-use (U-2837)US 92730772.7y
FDA exclusivities (3)
- May 22, 2027ODE-300Orphan Drug (7y)267d
- May 22, 2027ODE-300Orphan Drug (7y)267d
- May 22, 2027ODE-300Orphan Drug (7y)267d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that